Citigroup
CVAC

Citigroup’s CureVac CVAC Stock Holding History

Citigroup’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-216,875
Closed -$1.17M – 6137
2025
Q3 		$1.17M Buy
216,875
+168,916
+352% +$914K ﹤0.01% 3064
2025
Q2 		$260K Buy
47,959
+34,861
+266% +$138K ﹤0.01% 3941
2025
Q1 		$36.3K Sell
13,098
-878
-6% -$3.06K ﹤0.01% 4967
2024
Q4 		$47.7K Buy
13,976
+5,677
+68% +$16.4K ﹤0.01% 5100
2024
Q3 		$24.4K Sell
8,299
-1,316
-14% -$4.33K ﹤0.01% 5153
2024
Q2 		$32.7K Buy
9,615
+3,791
+65% +$12.4K ﹤0.01% 4814
2024
Q1 		$17.6K Sell
5,824
-3,776
-39% -$13.3K ﹤0.01% 5070
2023
Q4 		$40.4K Sell
9,600
-476
-5% -$2.58K ﹤0.01% 4635
2023
Q3 		$68.8K Sell
10,076
-3,415
-25% -$30.2K ﹤0.01% 4044
2023
Q2 		$141K Buy
13,491
+1,253
+10% +$11.2K ﹤0.01% 4074
2023
Q1 		$85.3K Sell
12,238
-1,489
-11% -$13K ﹤0.01% 4086
2022
Q4 		$82.8K Buy
13,727
+5,541
+68% +$40.9K ﹤0.01% 4093
2022
Q3 		$64K Sell
8,186
-954
-10% -$11.1K ﹤0.01% 4284
2022
Q2 		$124K Sell
9,140
-7,329
-45% -$121K ﹤0.01% 4101
2022
Q1 		$323K Sell
16,469
-21,823
-57% -$436K ﹤0.01% 3791
2021
Q4 		$1.31M Sell
38,292
-95,446
-71% -$3.84M ﹤0.01% 2978
2021
Q3 		$7.3M Sell
133,738
-45,189
-25% -$2.72M ﹤0.01% 1579
2021
Q2 		$13.1M Buy
178,927
+176,462
+7,159% +$17.6M 0.01% 1246
2021
Q1 		$225K Buy
2,465
+1,800
+271% +$175K ﹤0.01% 3951
2020
Q4 		$54K Buy
665
+565
+565% +$43.3K ﹤0.01% 5975
2020
Q3 		$5K Buy
+100
New +$5.58K ﹤0.01% 6992

Other funds holding CVAC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Citigroup's CVAC Position: Q4 2025 in Review

Citigroup sold out of CureVac (CVAC) in Q4 2025, closing a stake of 216,875 shares — an estimated $1.17M sold.

Citigroup first reported a position in CVAC in Q3 2020 and held it in 21 quarters. The position peaked at $13.1M in Q2 2021. 57 funds tracked by Wall St. Rank hold CVAC as of Q4 2025.

  • Citigroup reported no remaining CureVac position as of Q4 2025 after selling out during the quarter.
  • Citigroup sold 216,875 CureVac shares in Q4 2025, an estimated $1.17M.
  • Citigroup first reported a position in CureVac in Q3 2020 and held it in 21 quarters.
  • Citigroup's CureVac position peaked at $13.1M in Q2 2021.
  • 57 funds tracked by Wall St. Rank held CureVac as of Q4 2025.

Based on Citigroup's 13F filing for Q4 2025, filed 13 Feb 2026.